IPF is a progressive lung disease that causes tissue in the lungs to become scarred, thick and stiff. These changes in the tissue make the lungs unable to transport oxygen into the bloodstream as effectively as they used to.1
The most common symptoms of IPF are a dry cough and shortness of breath, but some people may also experience weight loss and loss of appetite. Some people may also develop other lung conditions including but not limited to lung cancer, pneumonia and blood clots in the lungs.1
A person’s risk for IPF is higher if they smoke or there is a family history of IPF. Additionally, the risk of IPF increases with age. How IPF advances also varies between people – some people may experience scarring in the lung tissue quickly or slowly, or their condition can stay the same for years.2
There is no cure for IPF; however, certain medicines may slow the progression of IPF. Clinical research studies and volunteer participants are vital to the development of medicines that can slow disease progression in people with IPF. To see if you may be eligible to join us in this important research, we invite you to click or tap the button below to see if you qualify.
See if you qualify